Physicochemical & Biological Assessment of Lyophilized Trastuzumab Formulation Containing Trehalose & Peg: A Central Composite Design

S Dehghani Tafti - … & Biological Assessment of Lyophilized Trastuzumab … - papers.ssrn.com
The current study aimed to find the best combination of trehalose and polyethylene glycol
4000 (PEG4000) in Trastuzumab lyophilized formulation. Trehalose and PEG4000 varied …

[HTML][HTML] Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at various temperatures

M Paul, A Astier, V Vieillard - GaBI J, 2018 - gabi-journal.net
Objectives: This study assessed the long-term stability of the trastuzumab biosimilar CT-P6
(Herzuma®, Biogaran) in vials under various storage conditions; after reconstitution of the …

Freeze thaw and lyophilization induced alteration in mAb therapeutics: trastuzumab as a case study

R Dash, AS Rathore - Journal of Pharmaceutical and Biomedical Analysis, 2021 - Elsevier
Long-term stability of therapeutic monoclonal antibody (mAb) products is necessary for their
successful commercialization. Freeze-thaw (F/T) operations are often performed for a mAb …

A comparative study on the physicochemical and biological stability of IgG1 and monoclonal antibodies during spray drying process

V Ramezani, A Vatanara, AR Najafabadi… - DARU Journal of …, 2014 - Springer
Background The main concern in formulation of antibodies is the intrinsic instability of these
labile compounds. To evaluate the physicochemical stability of antibody in dry powder …

The effect of freeze-dried antibody concentrations on its stability in the presence of trehalose and hydroxypropyl-β-cyclodextrin: A box–behnken statistical design

H Faghihi, F Khalili, M Amini… - Pharmaceutical …, 2017 - Taylor & Francis
The present study aimed at preparation and optimization of stable freeze-dried
immunoglobulin G (IgG) applying proper amount of antibody with efficient combination of …

Implementation of Design of Experiments (DOE) for Optimization of Feeding Strategy and Glyco-Engineering of Trastuzumab Biosimilar

R Mahboudi, S Samavat, A Afrah, M Khorshidtalab… - bioRxiv, 2019 - biorxiv.org
Fed-batch cell culture is the most commonly used process for antibody production in
biopharmaceutical industries. Basal media, feed, feeding strategy and glycan structures are …

Focused physicochemical stability study of reconstituted trastuzumab biosimilar SB3 (Ontruzant®) stored in the original vials over 28 days

L Knoll, J Thiesen, I Krämer - Pharmaceutical Technology in Hospital …, 2024 - degruyter.com
Abstract Objective Trastuzumab biosimilar SB3 (Ontruzant®), a HER2 binding monoclonal
antibody, is available as powder for concentrate for solution for infusion. According to the …

Amino Acid‐Based Advanced Liquid Formulation Development for Highly Concentrated Therapeutic Antibodies Balances Physical and Chemical Stability and Low …

K Kemter, J Altrichter, R Derwand… - Biotechnology …, 2018 - Wiley Online Library
To develop highly concentrated therapeutic antibodies enabling convenient subcutaneous
application, well stabilizing pharmaceutical formulations with low viscosities are considered …

Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time …

J Massant, S Fleurime, M Batens… - European Journal of …, 2020 - Elsevier
To increase their stability, therapeutic (or monoclonal) antibodies (mAbs) are often
formulated as solids by using a variety of drying techniques, eg freeze-drying, spray-drying …

Physiochemical stability of diluted trastuzumab infusion solutions in polypropylene infusion bags

J Kaiser, I Kramer - International Journal of Pharmaceutical Compounding, 2011 - ijpc.com
The purpose of this study was to determine the physicochemical stability of ready-to
administer trastuzumab infusion solutions in 0.9% sodium chloride solution as the vehicle …